| NDC Code | 10135-742-30 |
|---|
| Package Description | 30 TABLET in 1 BOTTLE (10135-742-30) |
|---|
| Product NDC | 10135-742 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Bisoprolol Fumarate And Hydrochlorothiazide |
|---|
| Non-Proprietary Name | Bisoprolol Fumarate And Hydrochlorothiazide |
|---|
| Dosage Form | TABLET |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20220501 |
|---|
| Marketing Category Name | ANDA |
|---|
| Application Number | ANDA215562 |
|---|
| Manufacturer | Marlex Pharmaceuticals, Inc. |
|---|
| Substance Name | BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE |
|---|
| Strength | 10; 6.25 |
|---|
| Strength Unit | mg/1; mg/1 |
|---|
| Pharmacy Classes | Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS], beta-Adrenergic Blocker [EPC] |
|---|